Le Lézard
Classified in: Science and technology
Subjects: Contract/Agreement, Share Issue

voxeljet AG Announces Pricing of $4.4 Million Registered Direct Offering


voxeljet AG (WKN: A2QBGM / ISIN: US92912L2060) (NASDAQ: VJET) (the "Company", or "voxeljet"), a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of 1,279,070 Ordinary Shares at a purchase price of $3.44 per share (this equals EUR 3.60 per Ordinary Share based on the exchange rate as of the close of business in New York on September 28, 2022) in the form of American Depositary Receipts in a registered direct offering. The closing of the offering is expected to occur on or about October 11, 2022, subject to the satisfaction of customary closing conditions.

A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.

This offering is being made pursuant to an effective shelf registration statement on Form F-3 (File No. 333-255911) previously filed with the U.S. Securities and Exchange Commission (the "SEC"). A prospectus supplement related to the capital increase and the proposed offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Electronic copies of the prospectus supplement may be obtained, when available, from the Company or from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at [email protected]. Before investing in this offering, interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Important Additional Information

This announcement is neither an advertisement nor a prospectus and does not constitute a recommendation with respect to the securities described in this announcement.

Forward-Looking Statements

To the extent this document contains forward-looking statements, such statements are not statements of fact and are made using words such as "expect", "believe", "estimate", "intend", "strive", "assume" and similar expressions. These statements are an expression of the intentions, views or current expectations and assumptions of voxeljet AG and are based on current plans, estimates and forecasts made by voxeljet AG on the basis of its best knowledge, but do not constitute any statement with respect to their future accuracy. You should not place undue reliance on these statements. voxeljet AG cannot provide assurances that the matters described in this press release will be successfully completed or that voxeljet AG will realize the anticipated benefits of any transaction. Forward-looking statements are subject to risks and uncertainties, which are usually difficult to predict and ordinarily not in the domain of influence of voxeljet AG. These risks and other factors are discussed in more detail in the company's public filings with the SEC. It should be noted that actual events or developments could materially differ from the events and developments described or included in the forward-looking statements. Statements made herein are as of the date hereof and should not be relied upon as of any subsequent date. The company disclaims any obligation to update any forward-looking statements except as may be required by law.


These press releases may also interest you

at 11:00
PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of LaNeotm MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has...

at 10:57
SparkFun Electronics is thrilled to announce the launch of the RTK Torch, an ultra-durable and highly-accurate GNSS product made to adapt to a variety of use cases and environments. Under its waterproof hood, the RTK Torch boasts an ESP32, a UM980...

at 10:53
Co-founder and CEO, Andrew Mignatti, of healthcare technology company, careviso, spoke at The Third Virtual National Health Care Transparency and No Surprises Act Summit. Mignatti's presentation centered around the existing transparency legislation...

at 10:45
Sensors act as a middle ground between the physical and digital. They measure all sorts of variables from touch, temperature, and heart rate across many different sectors, which IDTechEx's report "Printed and Flexible Sensors 2024-2034: Technologies,...

at 10:35
The "Public Affairs and Advocacy Software Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's offering. Global Public Affairs and Advocacy Software Market was valued...

at 10:33
Two next-generation imaging instruments designed by Raytheon, an RTX business, launched yesterday as part of Maxar's WorldView Legion satellites. These are the first two of six planned WorldView Legion satellites, which will provide a significant...



News published on and distributed by: